TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04109092

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Cause of deathFunding or business, also slow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“There was no enrolment of participants.Unscheduled Clinical Study Closure - Eisai Network Company Decision, November 12, 2020.”

The sponsor’s own words in the registry.

Life of this trial

201920202021Registered2019-08-27Planned start2020-02-13 (planned)Withdrawn (as of)2020-12-14

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
Eisai Inc.
Sponsor type
Industry
Conditions
Urinary Bladder Neoplasms
Interventions
E7766
Participants
0
Sites
9
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.